Skip to search formSkip to main contentSkip to account menu

allergovit

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
OBJECTIVE To evaluate the effect and safety analysis of Allergovit standardized dust mite subcutaneous immunotherapy in patients… 
2012
2012
AbstractBackground: The safety and efficacy of subcutaneous immunotherapy (SCIT) with the high-dose hypoallergenic preparations… 
2006
2006
OBJECTIVE To analyse the safety of Allergovit immunotherapy in patients of allergic rhinitis. METHOD Two hundred and fifty-six… 
2005
2005
Background: Various controlled clinical trials have proven the efficacy and safety of a short-term specific immunotherapy (SIT… 
2002
2002
Specific immunotherapy (SIT) can in some cases influence the course of allergic inflammation (eosinophilia and ECP concentration… 
2001
2001
BACKGROUND Specific immunotherapy (SIT) is probably the only causative treatment in allergic diseases including pollinosis. It is… 
1997
1997
UNLABELLED The aim of this study was to compare the efficacy of the immunotherapy by Allergovit and Catalet. 699 patient in age 5… 
1997
1997
The immunotherapy among patients with pollen allergy was performed by individuals composed Allergovit. The effects of this… 
1995
1995
The aim of this study was to evaluate the efficacy, tolerance and immunogenity of allergenic extracts: Allergovit and Novo…